Via TGF- β 1, IgA, and other tissue-protective, anti-inflammatory, and anti-tumor molecules, TLR-stimulated FDCs uniquely regulate mucosal homeostasis and prevent excessive activation that causes inflammation, autoimmunity, or tumor formation in the gut (Suzuki et al., 2010). This evidence concerns the gene CD79A and neoplasm.